In South San Francisco, Genentech showed that recombinant DNA technology could transform medicine and create therapies once ...

Zion Market Research has published a new research report titled 'Generative AI in Healthcare Market By Component (Solutions and Services), By Function (Medical Imaging & Diagnostics, Drug Discovery & ...

As climate change brings longer droughts, more frequent heat waves and increasingly unpredictable growing conditions to ...

German engineering company GEA is relocating its Application and Technology Center for future food from Hildesheim to ...

In a note dated Monday, the brokerage said hyperscalers — an industry term for tech companies that are spending big on data ...

Novartis AG NVS has agreed to acquire privately held U.K. biotechnology company Myricx Bio in a deal valued at up to $1.5 ...

Morgan Stanley’s pivot is from “chip winners” to hyperscalers with AI infrastructure optionality. MSFT has the strongest mix ...

Hospitals and health systems are rapidly adopting AI-powered tools, connected medical devices, advanced analytics and emerging biotechnology solutions. Most organizations evaluate these technologies ...

Elicio Therapeutics, Inc. (Nasdaq: ELTX) ('Elicio” or the 'Company”), a clinical-stage biotechnology company developing next-generation immunotherapies for KRAS-driven cancers, today announced the ...

Transparency and intellectual property are crucial when it concerns money being spent towards public interest.

Agriculture and food systems are the foundation of human society. Agricultural cooperation is essential for enhancing the ...

Genmab A/S(Nasdaq: GMAB) announced today that the European Commission (EC) granted marketing authorization for TEPKINLY ® (epcoritamab) in combination with lenalidomide and rituximab (TEPKINLY + R 2 ) ...